Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
University of Rochester
Children's Hospital Los Angeles
NYU Langone Health
Mayo Clinic
Royal Marsden NHS Foundation Trust
Second Affiliated Hospital, School of Medicine, Zhejiang University
Beijing 302 Hospital
H. Lee Moffitt Cancer Center and Research Institute
The First Affiliated Hospital of Zhengzhou University
Cardiff University
Assistance Publique - Hôpitaux de Paris
University of Colorado, Denver
University of California, San Diego
University of California, San Francisco
Second Xiangya Hospital of Central South University
Tongji Hospital
Radboud University Medical Center
Sichuan University
Hospital San Carlos, Madrid
Peking University
Sichuan University
Institut Paoli-Calmettes
Zhongnan Hospital
University of Chicago
Shanghai Junshi Bioscience Co., Ltd.
H. Lee Moffitt Cancer Center and Research Institute
Tang-Du Hospital
Gustave Roussy, Cancer Campus, Grand Paris
Yale University
University of Maryland, Baltimore
Abramson Cancer Center at Penn Medicine
West China Hospital
Biotech Pharmaceutical Co., Ltd.
University of Utah
University of Southern California
St. Jude Children's Research Hospital
University of Alabama at Birmingham
University of Chicago
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Centro Hospitalar Nordeste
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Memorial Sloan Kettering Cancer Center